Braidwell LP Boosts Stake in Globus Medical

Institutional investor increases holdings in medical device company by over 100%

Mar. 15, 2026 at 8:57am

Got story updates? Submit your updates here. ›

Braidwell LP, an institutional investor, grew its stake in Globus Medical, Inc. (NYSE:GMED) by 101.5% in the third quarter, according to a recent SEC filing. The firm now owns 498,000 shares of the medical device company's stock, worth approximately $28.5 million.

Why it matters

Globus Medical is a leading manufacturer of spinal implants and surgical instruments. This significant increase in institutional ownership signals continued confidence in the company's growth prospects and competitive position within the orthopedics market.

The details

Braidwell LP added 250,800 shares to its existing Globus Medical holdings, bringing its total stake to 498,000 shares or 0.37% of the company. This follows a broader trend of increased institutional investment in Globus Medical, with other firms like EverSource Wealth Advisors LLC and Parallel Advisors LLC also boosting their positions in recent quarters.

  • Braidwell LP increased its Globus Medical stake in the third quarter of 2026.

The players

Braidwell LP

An institutional investor that has significantly increased its ownership stake in Globus Medical, Inc.

Globus Medical, Inc.

A leading medical device company specializing in musculoskeletal solutions for spine and orthopedic applications.

Got photos? Submit your photos here. ›

The takeaway

This investment by Braidwell LP underscores the positive sentiment surrounding Globus Medical and its potential for continued growth in the orthopedics market. As the company expands its product portfolio and explores new technologies like robotics, it remains an attractive investment for institutional investors.